GLAXOSMITHKLINE LLC
Patent Owner
Stats
- 503 US PATENTS IN FORCE
- 12 US APPLICATIONS PENDING
- Mar 06, 2018 most recent publication
Details
- 503 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 13,202 Total Citation Count
- Nov 02, 1988 Earliest Filing
- 335 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0057,582 METHODS OF TREATMENT OF EOSINOPHILIC BRONCHITIS WITH AN ANTI-IL-5 ANTIBODYNov 06, 17Mar 01, 18[A61K, C07K]
2017/0367,648 METHODS FOR DETERMINING TOTAL BODY SKELETAL MUSCLE MASSJul 10, 17Dec 28, 17[H01J, G01N, A61B]
2017/0157,113 4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1 H-IMIDAZO[4,5-C]QUINOLIN-7-YL)-3,5-DIMETHYLISOXAZOLE AND ITS USE AS BROMODOMAIN INHIBITORFeb 17, 17Jun 08, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9907847 Pyrrolopyrimidines as therapeutic agents for the treatment of diseasesDec 06, 16Mar 06, 18[A61K, C07D]
9861627 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitorFeb 17, 17Jan 09, 18[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0106,756 BENZODIAZEPINES FOR TREATING SMALL CELL LUNG CANCERAbandonedDec 21, 15Apr 21, 16[A61K]
2016/0002,273 THIENO[3,2-D]PYRIMIDINE-6-CARBOXAMIDES AND ANALOGUES AS SIRTUIN MODULATORSAbandonedMar 07, 14Jan 07, 16[C12Q, C07F, C07D]
2015/0322,082 NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORSAbandonedNov 22, 13Nov 12, 15[C07D]
2015/0238,507 BENZODIAZEPINES FOR TREATING SMALL CELL LUNG CANCERAbandonedAug 14, 13Aug 27, 15[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
